John Weiler, CompleWare Corporation, United States
John M. Weiler, M.D., M.B.A. is President of CompleWare Corporation, a technology provider and CRO. Dr. Weiler was one of the three founding members of the eClinical SIAC and is chair of the new SE SIAC.
PRESENTER
(S):
John Powers, SAIC/National Institutes of Health, United States
Dr. Powers is a physician/investigator and an internist and specialist in infectious diseases. Dr Powers has particular expertise in the design, conduct and analysis of clinical trials and has published numerous articles and book chapters in this area.
The SEALD Staff leads review and policy development related to the use of clinical outcome assessments in clinical trials to support medical product development and labeling or promotion claims of treatment benefit.
Description
This showcase will discuss the taxonomy of study endpoints and how this is important in study design. Developed by the Study Endpoints (SE) SIAC.
Learning Objectives: Explain the importance of taxonomy in selecting study endpoints in clinical trials.